You're reading the free version. Trader adds the live tape and alerts.
Start tracking
APRE Award Disclosure
Bizzari Jean-pierre · SEC Form 4 · Filed Jun 17, 2026
Award
Calculated transaction value
$0
Bizzari Jean-pierre Director
APRE
Transaction date
Jun 16, 2026
Public filing date
Jun 17, 2026
Filing lag
Filed 1 day later
APRE daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,135 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001104659-26-075281
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Aprea Therapeutics, Inc. APRE Current | Award | Jun 16, 2026 | $0 |
| Aprea Therapeutics, Inc. APRE | Award | Jun 16, 2026 | $0 |